Interplay between coronaviruses and nonsense-mediated mRNA decay pathway
冠状病毒与无义介导的 mRNA 衰减途径之间的相互作用
基本信息
- 批准号:10358595
- 负责人:
- 金额:$ 30.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-11 至 2024-02-28
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAddressAreaAttenuatedBindingBinding ProteinsBiologicalBiological ModelsBiologyCellsClinicalCommon ColdCoronavirusCoronavirus nucleocapsid proteinCountryCytoplasmDataDevelopmentDiseaseDomestic AnimalsElementsEnsureEpidemicEuropeExhibitsFar EastGene ExpressionGenerationsGenetic DiseasesGenomeHost Defense MechanismHumanIntronsKnowledgeLeadMeasuresMediatingMessenger RNAMiddle EastMiddle East Respiratory SyndromeMiddle East Respiratory Syndrome CoronavirusMolecularMurine hepatitis virusNonsense-Mediated DecayNorthern AfricaOpen Reading FramesPathogenicityPathway interactionsPhenotypePhosphorylationPhysiologicalPlayPost-Transcriptional RegulationPredispositionProteinsPublic HealthQuality ControlRNARNA VirusesRNA-Binding ProteinsResearchRespiratory SystemRoleSARS coronavirusSaudi ArabiaSevere Acute Respiratory SyndromeStructureSymptomsTerminator CodonTestingTherapeutic AgentsTimeTranscriptVaccinesViralViral Gene Expression RegulationViral GenesViral N ProteinViral ProteinsVirusVirus AssemblyVirus Replicationcoronavirus vaccineeconomic impactendonucleasegene producthuman coronavirusinhibitorinsightmRNA DecaymRNA StabilitymRNA Surveillancemortalitymutantnovelnovel strategiesprematurepreventrecruitrespiratoryvaccine candidateviral RNAvirology
项目摘要
Coronaviruses (CoVs), which carry a large, single-stranded, positive-sense RNA genome, cause a variety of
diseases in humans and domestic animals. Human CoVs (HCoVs) usually infect the respiratory tract and
cause a range of symptoms varying from mild, such as the common cold, to more serious respiratory illnesses
like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), caused by two
highly pathogenic HCoVs, SARS-CoV and MERS-CoV. SARS-CoV caused a worldwide epidemic in 2002-
2003, resulting in more than 8,000 cases with an approximate mortality of 10%, while MERS-CoV emerged in
Saudi Arabia in 2012 and has been disseminated into other countries in the Middle East, North Africa, Europe,
and East Asia. HCoVs represent a major threat to public health and have the potential to cause a significant
negative economic impact. Currently, there are no approved vaccines and therapeutic agents against HCoVs.
The development of effective control measures against CoVs requires a comprehensive understanding of viral
gene expression strategies and host-CoV interactions. A plethora of studies have focused on investigating CoV
biology and have significantly contributed to our understanding of CoV replication mechanisms, including the
structure-function analyses of viral RNA elements as well as the viral proteins that are involved in viral
replication and assembly. However, there are still gaps in our knowledge of the post-transcriptional regulation
of viral gene expression, as only a limited number of studies have addressed this area of CoV research.
Particularly, very little is known about the cis-acting viral RNA elements and trans-acting host and viral factors
that regulate CoV mRNA transcript stability. One newly emerging research area in virology is understanding
interactions between viruses and host mRNA surveillance pathways that prevent generation/accumulation of
unwanted gene products. We have demonstrated that CoV mRNAs are the targets of the nonsense-mediated
mRNA decay (NMD) pathway, one of the host mRNA surveillance pathways, and that viral N protein protects
CoV mRNAs from NMD. Our data suggest the importance of N-mediated NMD suppression for efficient virus
replication. The present application will study the interplay between the NMD pathway and CoVs by testing the
following hypotheses: UPF1, the principal orchestrator of NMD, binds to the 3’ UTR of CoV mRNAs having
specific motifs, undergoes phosphorylation, and recruits SMG6, an endonuclease, leading to endonucleolytic
RNA cleavage; N binds to the 3’ UTRs of NMD targets and prevents an NMD factor(s) from accessing these
targets and/or N interacts with an NMD factor(s) and sequesters it away from the NMD pathway; and CoV
mutants having an increased susceptibility to NMD, cannot replicate as efficiently as the parental viruses. The
data obtained from these studies will provide mechanistic insights into NMD of CoV mRNAs and N-mediated
NMD pathway suppression, and will reveal the feasibility of novel strategies for attenuating CoVs through
increased susceptibility to the NMD pathway.
冠状病毒 (CoV) 携带大型单链正链 RNA 基因组,可引起多种疾病
人类和家畜的疾病通常会感染呼吸道和呼吸道。
引起一系列症状,从普通感冒等轻微症状到更严重的呼吸道疾病
例如严重急性呼吸系统综合症(SARS)和中东呼吸系统综合症(MERS),由两种疾病引起
高致病性 HCoV、SARS-CoV 和 MERS-CoV 于 2002 年引起了全球流行。
2003 年,导致 8,000 多例病例,死亡率约为 10%,而 MERS-CoV 出现在
2012年在沙特阿拉伯上市,并已传播到中东、北非、欧洲等其他国家,
HCoV 对公共卫生构成重大威胁,并有可能造成重大影响。
负面经济影响。目前,还没有针对 HCoV 的疫苗和治疗药物获得批准。
制定针对冠状病毒的有效控制措施需要全面了解病毒
大量研究集中于研究 CoV 的基因表达策略和宿主与 CoV 的相互作用。
生物学,并为我们对冠状病毒复制机制的理解做出了重大贡献,包括
病毒RNA元件以及参与病毒感染的病毒蛋白的结构功能分析
然而,我们对转录后调控的了解仍然存在差距。
病毒基因表达的研究,因为只有有限数量的研究涉及到 CoV 研究的这一领域。
特别是,对于顺式作用病毒RNA元件和反式作用宿主和病毒因子知之甚少
病毒学中一个新兴的研究领域是理解 CoV mRNA 转录稳定性。
病毒和宿主 mRNA 监视途径之间的相互作用,防止产生/积累
我们已经证明 CoV mRNA 是无义介导的目标。
mRNA 衰减 (NMD) 途径是宿主 mRNA 监视途径之一,病毒 N 蛋白可保护
我们的数据表明 N 介导的 NMD 抑制对于有效病毒的重要性。
本申请将通过测试 NMD 途径和 CoV 之间的相互作用。
以下假设:UPF1 是 NMD 的主要协调者,与具有以下特征的 CoV mRNA 的 3’UTR 结合:
特定基序,经历磷酸化,并招募 SMG6(一种核酸内切酶),导致核酸内切
RNA 裂解;N 与 NMD 靶标的 3' UTR 结合并阻止 NMD 因子访问这些目标
目标和/或 N 与 NMD 因子相互作用,并将其隔离于 NMD 途径和 CoV 之外;
对 NMD 敏感性增加的突变体不能像亲代病毒那样有效地复制。
从这些研究中获得的数据将为 CoV mRNA 和 N 介导的 NMD 提供机制见解
NMD 通路抑制,并将揭示通过以下方式减弱 CoV 的新策略的可行性
对 NMD 途径的敏感性增加。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shinji Makino其他文献
Shinji Makino的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shinji Makino', 18)}}的其他基金
Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus
裂谷热白蛉病毒包膜糖蛋白识别病毒RNP的机制及其在RNA片段包装中的作用
- 批准号:
10057583 - 财政年份:2020
- 资助金额:
$ 30.92万 - 项目类别:
Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus
裂谷热白蛉病毒包膜糖蛋白识别病毒RNP的机制及其在RNA片段包装中的作用
- 批准号:
10188412 - 财政年份:2020
- 资助金额:
$ 30.92万 - 项目类别:
Interplay between coronaviruses and nonsense-mediated mRNA decay pathway
冠状病毒与无义介导的 mRNA 衰减途径之间的相互作用
- 批准号:
10614383 - 财政年份:2020
- 资助金额:
$ 30.92万 - 项目类别:
Rational Development of a Novel Attenuated Rift Valley Fever Virus Vaccine
新型裂谷热病毒减毒疫苗的合理研制
- 批准号:
9386475 - 财政年份:2017
- 资助金额:
$ 30.92万 - 项目类别:
Development of Safer,Live Attenuated Rift Valley Fever Vaccines
开发更安全的裂谷热减毒活疫苗
- 批准号:
9091408 - 财政年份:2015
- 资助金额:
$ 30.92万 - 项目类别:
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1
MERS 冠状病毒 nsp1 宿主和病毒基因调控的新范式
- 批准号:
9189963 - 财政年份:2015
- 资助金额:
$ 30.92万 - 项目类别:
Development of a Novel Rift Valley Fever Virus Vaccine
新型裂谷热病毒疫苗的开发
- 批准号:
8604678 - 财政年份:2013
- 资助金额:
$ 30.92万 - 项目类别:
Development of a Novel Rift Valley Fever Virus Vaccine
新型裂谷热病毒疫苗的开发
- 批准号:
8509347 - 财政年份:2013
- 资助金额:
$ 30.92万 - 项目类别:
Analysis of Coronavirus-Host Cell Interactions
冠状病毒-宿主细胞相互作用分析
- 批准号:
8442842 - 财政年份:2012
- 资助金额:
$ 30.92万 - 项目类别:
Analysis of Coronavirus-Host Cell Interactions
冠状病毒-宿主细胞相互作用分析
- 批准号:
8888201 - 财政年份:2012
- 资助金额:
$ 30.92万 - 项目类别:
相似海外基金
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)
开发 Utropin 位点封闭寡核苷酸 (SBO) 来治疗杜氏肌营养不良症 (DMD)
- 批准号:
10678195 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别: